| Pharmaceutical active ingredients: |
| Bromhexine HydrochlorideErythromycin Stearate |
| Available forms, composition and doses of Eriwest: |
| N / A |
| Eriwest medical category: |
| Human |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| D10AF52 - Erythromycin, combinations |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bruluagsa |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ero-B | Bromhexine Hydrochloride; Erythromycin Estolate | Lupin Pharmaceuticals |
| Broncolitic | Bromhexine Hydrochloride; Erythromycin Estolate; Guaiacol Cinnamate | Chiesi |
| Bisolvonat | Bromhexine Hydrochloride; Erythromycin Ethylsuccinate | Boehringer Ingelheim |
| Synergomycin | Bromhexine Hydrochloride; Erythromycin Ethylsuccinate | Abbott |
| Alibron | Bromhexine Hydrochloride; Erythromycin Propionate | Boehringer Ingelheim |
| Pantobron | Bromhexine Hydrochloride; Erythromycin; Erythromycin Ethylsuccinate | Abbott |
| Berosolvon | Bromhexine Hydrochloride; Fenoterol Hydrobromide | Boehringer Ingelheim |
| Berotec Solvens | Bromhexine Hydrochloride; Fenoterol Hydrobromide | Boehringer Ingelheim |
| Solvelin | Bromhexine Hydrochloride; Feprazone | Istituto de Angeli |
| Mitibron | Bromhexine Hydrochloride; Fibracillin; Guaifenesin | Sanofi-Aventis |